Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model

Doxorubicin is currently the most effective chemotherapeutic drug used to treat breast cancer. It has, however, been shown that doxorubicin can induce drug resistance resulting in poor patient prognosis and survival.